Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies
Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.
2020 OBIO Capital Access Advisory Program - Call for Applications
2020 Call for Applications - NOW OPEN. OBIO CAAP® is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an expansive network of health science industry experts and investors to enhance the ability of OBIO CAAP companies to secure financing.
FedDev Ontario announces $6.24 million investment in OBIO
FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.
OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2020 Niagara Investment Summit
The OBIO 2020 Niagara Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.
Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario
The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
OBIO Announces Launch of OBIO CAAP® for 2019
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s program.
OBIO Announces Successful 2019 Niagara Investment Summit
OBIO® (Ontario Bioscience Innovation Organization) is proud to announce the success of the 2019 Niagara Investment Summit on February 20-22, 2019. The 2019 Niagara Investment Summit featured over 30 of Canada’s most promising innovative health science companies and more than 30 US and global investors and VCs.
OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors
OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.
Ontario Bioscience Innovation Organization Announces a National Call to Companies for Applications for the 2019 Niagara Investment Summit
OBIO is proud to announce a national call for applications from health science companies, seeking Series A and beyond investments, to present at the 2019 Niagara Investment Summit, February 20-22, 2019.
OBIO Completes Successful Canadian Health Investment Showcase in New York City
The Ontario Bioscience Innovation Organization (OBIO®) is honoured to announce the conclusion of the successful Canadian Health Investment Showcase which took place in New York, NY, on November 5 and 6, 2018.
OBIO Opens Canadian Health Investment Showcase in New York City, Connecting Canada’s High Potential Health Science Companies with Premier US Investors
OBIO Launches 'Use It or Lose It', Latest Report on the Future of Canada’s Health Science Industry
The Ontario Bioscience Innovation Organization (OBIO®) released its latest report, ‘Use It or Lose It: Industry Solutions to Ontario’s Commercialization Gap’, with recommendations from health science company executives on how to create the conditions for the growth of Ontario’s health science industry.
Press Release: OBIO CAAP Companies Raise More Than $109 Million in Investments
Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit membership based organization that is Ontario’s leading advocate for the health science industry, announced today that Ontario health science companies that have participated in its Capital Access Advisory Program (CAAP®) have raised more than $109 Million since the CAAP program launched in 2013.
Ontario Bioscience Innovation Organization (OBIO®) Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry
January 24, 2017 TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) hosted a summit of industry, academic, government and investment leaders about the future of health science innovation in Canada. Attendees engaged in group discussions and heard from subject matter experts to extrapolate a mandate of action for anchoring health science companies in Ontario. The outcome of the summit lays a foundation for actionable business cases for private and public sector solutions to the health science industry’s biggest challenges: Innovation Pull, Adoption and Capital Attraction.
Versant Ventures Closes 6th Healthcare Fund
Versant Ventures has announced the close of its newest fund, Versant Venture Capital VI, at its hard cap of CAD538 million (USD400 million). Versant will use its diversified global investment strategy to find, form and fund innovative healthcare companies with an emphasis on novel therapeutics.
OBIO Announces New Public Relations & Communications Services Member Benefit
TORONTO, Dec. 7, 2016 - HOWE&WYE is proud to announce its new partnership with OBIO®. As a part of OBIO's new member benefit, HOWE&WYE will provide strategic public relations and communications services to OBIO's broad membership of world-class start-ups and bioscience companies. OBIO members will benefit from special access to top-tier agency support with optimized pricing to strengthen PR and marketing to fulfill strategic business outcomes for awareness, investment and commercialization.
OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry
Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2017 Capital Access Advisory Program
Toronto, Ontario, November 2, 2016 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit, organization that is Ontario’s leading advocate for the health science industry, is pleased to announce a call for applications for the 2017 OBIO Capital Access Advisory Program (CAAP®).
OBIO Launches Report in the Nation’s Capital
Ottawa, Ontario – June 21, 2016: Ontario Bioscience Innovation Organization (OBIO®) today initiated the Eastern leg of its Provincewide Tour in Ottawa to promote their recently released report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy”.
OBIO Launches Provincewide Report Tour - First Stop: Silicon Valley North
June 8, 2016. Kitchener. Ontario Bioscience Innovation Organization (OBIO®) today initiated the first leg of its Provincewide Tour to promote their recently released report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy”.
For the full press release, click here